| Jun'19 | Jun'18 | Jun'17 | Jun'16 | Jun'15 | Jun'14 | Jun'13 | Jun'12 | Jun'11 |
|---|---|---|---|---|---|---|---|---|
Net income | ||||||||
3,902 | 3,408 | 3,777 | 666 | -3,849 | -2,490 | 257 | -858 | -205 |
Depreciation and amortization | ||||||||
601 | 633 | 486 | 507 | 768 | 879 | 901 | 900 | 786 |
Stock compensation expense | ||||||||
551 | 588 | 1,266 | 1,010 | 2,760 | 1,719 | 843 | - | - |
Impairment of intangibles | ||||||||
- | - | - | 0 | 1,495 | 0 | 0 | - | - |
Bad debt expense | ||||||||
510 | 465 | 345 | 68 | 186 | 186 | 144 | - | - |
Bad debt expense | ||||||||
- | - | - | - | - | - | - | 260 | 57 |
Stock compensation expense | ||||||||
- | - | - | - | - | - | - | 911 | 862 |
Charitable non-cash donations | ||||||||
- | - | - | 0 | 157 | 96 | 0 | - | - |
Loss on short-term marketable securities | ||||||||
- | - | - | -26 | 0 | 0 | - | - | - |
Gain on sale of fixed assets | ||||||||
- | - | -10 | 0 | 0 | - | - | - | - |
Other gains | ||||||||
- | - | - | - | - | - | - | -319 | - |
Stock issued for litigation settlement | ||||||||
- | - | - | - | - | - | - | - | 375 |
Other gains | ||||||||
- | - | - | - | - | - | - | - | 0 |
Accounts receivables | ||||||||
312 | -4,180 | -2,325 | -1,975 | 710 | 661 | 1,859 | -491 | -667 |
Long-term receivables, prepaid and other assets | ||||||||
-383 | 854 | -1,257 | 70 | -501 | 20 | 226 | 97 | -85 |
Accounts payable | ||||||||
-960 | 924 | -14 | -236 | -49 | 84 | 102 | -184 | 216 |
Accrued liabilities | ||||||||
462 | -500 | 355 | -18 | 136 | 49 | -8 | 132 | -191 |
Deferred revenue | ||||||||
-417 | -15 | -366 | 385 | -107 | 63 | -304 | 418 | 298 |
Net cash provided by operating activities | ||||||||
4,578 | 2,179 | 2,257 | 503 | 1,707 | -92 | -149 | 866 | 1,446 |
Purchase of long-term investments | ||||||||
- | - | 6 | 75 | 0 | 0 | - | - | - |
Payments received on notes receivable | ||||||||
- | - | - | 0 | 300 | 0 | 0 | - | - |
Net cash received in acquisition | ||||||||
- | - | - | 0 | 22 | 0 | 0 | - | - |
Cash advanced on Note Receivable | ||||||||
- | - | - | 0 | -2,559 | -1,200 | 0 | - | - |
Cash from sale of property and equipment | ||||||||
- | - | 13 | 0 | 0 | 6 | 0 | - | - |
Purchase of property and equipment | ||||||||
1,447 | 204 | 1,957 | 80 | 369 | 459 | 445 | 238 | 358 |
Cash from sale of marketable securities | ||||||||
- | - | - | 4,612 | 0 | 0 | - | - | - |
Capitalization of software costs | ||||||||
0 | 111 | 0 | 182 | 0 | 0 | - | - | - |
Sale of long-term investments | ||||||||
-477 | 0 | - | - | - | - | - | - | - |
Purchase of marketable securities | ||||||||
- | - | 0 | 4,639 | 0 | 0 | - | - | - |
Capitalization of software costs | ||||||||
- | - | - | - | - | - | - | - | -197 |
Net cash used in investing activities | ||||||||
-969 | -315 | -1,950 | -365 | -2,606 | -1,652 | -445 | -238 | -555 |
Proceeds from exercise of options and warrants | ||||||||
- | - | - | - | - | - | - | 496 | 332 |
Proceeds from issuance of notes payable | ||||||||
1,268 | 56 | 1,824 | 0 | 172 | 338 | 176 | - | - |
Net increase in line of credit | ||||||||
- | - | - | - | - | - | - | - | -600 |
Proceeds from issuance of stock | ||||||||
- | - | - | 0 | 7,606 | 1,493 | 4,162 | 0 | 140 |
Net increase in lines of credit | ||||||||
1,430 | 380 | 350 | 0 | 1,300 | 0 | 0 | - | - |
Redemption of Series B-1 Preferred | ||||||||
0 | -999 | 0 | 0 | -7 | 0 | -21 | - | - |
Series A redemption | ||||||||
- | - | - | - | - | - | - | 0 | - |
Dividends paid | ||||||||
439 | 782 | 10 | 10 | 157 | 586 | 503 | 494 | 370 |
Common Stock buyback/retirement | ||||||||
482 | 0 | - | - | - | - | - | - | - |
Proceeds from issuance of note payable | ||||||||
- | - | - | - | - | - | - | 310 | 559 |
Proceeds from employee stock purchase plans | ||||||||
0 | 244 | 223 | 199 | 203 | 153 | 156 | 141 | - |
Proceeds from employee stock plan | ||||||||
164 | 666 | 156 | 33 | 0 | 633 | 0 | - | - |
Payments on notes payable and capital leases | ||||||||
1,833 | 591 | 239 | 242 | 245 | 551 | 866 | - | - |
Payments on notes payable and capital leases | ||||||||
- | - | - | - | - | - | - | 2,594 | 692 |
Net cash used in financing activities | ||||||||
108 | -1,025 | 2,304 | -19 | 8,872 | 1,481 | 3,105 | -2,139 | 569 |
Net increase in cash and cash equivalents | ||||||||
3,716 | 838 | 2,610 | 117 | 7,973 | -264 | 2,510 | -1,512 | 1,460 |
Cash paid for income taxes | ||||||||
76 | 75 | 66 | 0 | 0 | 6 | 0 | - | 0 |
Cash paid for interest | ||||||||
146 | 166 | 22 | - | - | - | - | - | - |
Cash paid for interest | ||||||||
- | - | - | 46 | 80 | 75 | 142 | 281 | 302 |
Preferred stock to pay accrued liabilities | ||||||||
0 | 200 | 300 | 400 | 300 | 0 | 0 | - | - |
Common stock to pay accrued liabilities | ||||||||
514 | 1,048 | 783 | 1,687 | 1,860 | 1,107 | 786 | 704 | 923 |
Dividends accrued on preferred stock | ||||||||
586 | 573 | 790 | 729 | 568 | 617 | 911 | 834 | 826 |
Dividends paid with preferred stock | ||||||||
- | - | 756 | 660 | 442 | 0 | 501 | 336 | 326 |
Conversion of accounts receivable into notes receivable | ||||||||
- | - | - | - | - | 1,622 | 1,622 | 0 | - |
Series B restructure | ||||||||
- | - | - | 0 | 2,141 | 0 | 0 | - | - |
Note payable for long-term investment | ||||||||
- | - | - | 396 | 0 | 0 | - | - | - |
Common stock issued | ||||||||
- | - | - | - | 10,821 | - | - | - | - |
Receivables eliminated in consolidation | ||||||||
- | - | - | - | 6,035 | - | - | - | - |
Cash received in acquisition | ||||||||
- | - | - | - | 22 | - | - | - | - |